Guaifenesin: The Ubiquitous Orphan.
Eyassu DG, McCoul ED.
Otolaryngol Head Neck Surg. 2024 Oct;171(4):1260-1261. doi: 10.1002/ohn.834. Epub 2024 May 28.
Cough medicines for children- time for a reality check.
Clark G, Fitzgerald DA, Rubin BK.
Paediatr Respir Rev. 2023 Dec;48:30-38. doi: 10.1016/j.prrv.2023.08.003. Epub 2023 Aug 17.
Ambroxol in the 21st century: pharmacological and clinical update.
Malerba M, Ragnoli B.
Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1119-29. doi: 10.1517/17425255.4.8.1119.
Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis.
O'Neill K, O'Donnell AE, Bradley JM.
Respirology. 2019 Mar;24(3):227-237. doi: 10.1111/resp.13459. Epub 2019 Jan 16.
Erdosteine.
Dechant KL, Noble S.
Drugs. 1996 Dec;52(6):875-81; discussion 882. doi: 10.2165/00003495-199652060-00009.
Physiology and pathophysiology of mucus and mucolytic use in critically ill patients.
Roe T, Talbot T, Terrington I, Johal J, Kemp I, Saeed K, Webb E, Cusack R, Grocott MPW, Dushianthan A.
Crit Care. 2025 Feb 7;29(1):68. doi: 10.1186/s13054-025-05286-x.
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
Poole P, Sathananthan K, Fortescue R.
Cochrane Database Syst Rev. 2019 May 20;5(5):CD001287. doi: 10.1002/14651858.CD001287.pub6.
[Expectoration and expectorants].
Ellorhaoui M, Rogos R.
Z Erkr Atmungsorgane Folia Bronchol. 1972;136(3):323-8.
Mucoactive drugs.
Balsamo R, Lanata L, Egan CG.
Eur Respir Rev. 2010 Jun;19(116):127-33. doi: 10.1183/09059180.00003510.
In celebration of expectoration: induced sputum indices as outcome measures in cystic fibrosis.
Armstrong DS.
Am J Respir Crit Care Med. 2003 Dec 15;168(12):1412-3. doi: 10.1164/rccm.2310001.
